GlassScriptPhysician profile
Jamie Lee Vanoveren
NPI 1447462841
$2,373.25
in general payments reported to CMS, 2019-2025
16 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $197 · 2021: $361 · 2022: $251 · 2023: $156 · 2024: $150 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $346 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $345.95 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uromedica, Incorporated | $1,009.86 | 2019 | |
| Astellas Pharma US INC | $352.52 | 2019-2023 | Myrbetriq |
| Boston Scientific Corporation | $252.93 | 2020-2024 | Moses 550 Dfl |
| Healthtronics Stone Solutions, LLC | $171.95 | 2019-2021 | |
| Calyxo, INC. | $120.64 | 2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $117.43 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $74.56 | 2019-2022 | |
| Abbvie INC. | $60.19 | 2024-2025 | |
| Myovant Sciences INC. | $39.19 | 2021-2022 | |
| Janssen Biotech, INC. | $35.23 | 2019-2024 | Erleada |
| Axonics, INC. | $31.31 | 2024 | Bulkamid |
| Immunitybio, INC. | $23.90 | 2024 | |
| Angiodynamics, INC. | $23.79 | 2021 | |
| Ferring Pharmaceuticals INC. | $21.67 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $21.23 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $16.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Vanoveren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.